Tag Archives: ACA
Healthcare’s $40B day: 5 things to know about Thursday’s mega-mergers
Some of the deal activity among medical device makers and pharmaceutical companies can be explained by the belief that gaining scale and becoming a leading provider is essential for effectively negotiating business with hospitals and insurers, according to The New York Times. Some of the impetus to consolidate can also be explained by the desire to acquire emerging product lines and biotech firms to supplement the declining sales of older products.
Covered California will exclude hospitals with high rates of C-sections
State want to bring down rate of Cesarean births to national target of 23.9 percent
Harvard Pilgrim bullish on exchange business despite high-profile UnitedHealthcare exit
Population health partnership key as New England insurer logs more and more enrollees.
Pharmacists critical to success in 5 value-based models
Three drug trends impacting specialty pharmacy
Will Covered California Sell Health Coverage To The Undocumented?
Health Care Transformation Task Force Reports Increase in Value-Based Payments
HENRY KOTULA 